# ROPIVACAINE HYDROCHLORIDE

NDC: 43066-154
Generic name: ROPIVACAINE HYDROCHLORIDE
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: EPIDURAL, INFILTRATION
Marketing started: 20240101

FDA application: ANDA210102

## Active ingredients

- ROPIVACAINE HYDROCHLORIDE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43066-154"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43066-154
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e057aeb2-5125-490c-b691-847426fd42d0